After finishing at $4.90 in the prior trading day, Ventyx Biosciences Inc (NASDAQ: VTYX) closed at $4.84, down -1.22%. In other words, the price has decreased by -$0.0600 from its previous closing price. On the day, 828784 shares were traded.
Ratios:
Our goal is to gain a better understanding of VTYX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.87 and its Current Ratio is at 11.87. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Wells Fargo on March 12, 2024, Upgraded its rating to Overweight and sets its target price to $16 from $7 previously.
On March 12, 2024, Oppenheimer Upgraded its rating to Outperform which previously was Perform but kept the price unchanged to $12.
Wells Fargo Downgraded its Overweight to Equal Weight on November 07, 2023, whereas the target price for the stock was revised from $77 to $8.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 02 ’24 when Mohan Raju sold 4,312 shares for $5.40 per share. The transaction valued at 23,299 led to the insider holds 1,578,250 shares of the business.
Krueger Christopher W sold 1,651 shares of VTYX for $8,921 on Apr 02 ’24. The CHIEF BUSINESS OFFICER now owns 284,999 shares after completing the transaction at $5.40 per share. On Apr 02 ’24, another insider, Nuss John, who serves as the CHIEF SCIENTIFIC OFFICER of the company, sold 1,651 shares for $5.40 each. As a result, the insider received 8,921 and left with 264,998 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VTYX now has a Market Capitalization of 341.22M and an Enterprise Value of 101.50M.
Stock Price History:
Over the past 52 weeks, VTYX has reached a high of $40.58, while it has fallen to a 52-week low of $1.87. The 50-Day Moving Average of the stock is 5.3675, while the 200-Day Moving Average is calculated to be 16.6989.
Shares Statistics:
The stock has traded on average 4.33M shares per day over the past 3-months and 1.56M shares per day over the last 10 days, according to various share statistics. A total of 59.24M shares are outstanding, with a floating share count of 47.09M. Insiders hold about 20.55% of the company’s shares, while institutions hold 89.16% stake in the company. Shares short for VTYX as of Mar 15, 2024 were 9.45M with a Short Ratio of 2.18, compared to 5.59M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 13.41% and a Short% of Float of 18.66%.
Earnings Estimates
Its stock is currently analyzed by 8 different market analysts. On average, analysts expect EPS of -$0.69 for the current quarter, with a high estimate of -$0.38 and a low estimate of -$0.86, while EPS last year was -$0.68. The consensus estimate for the next quarter is -$0.64, with high estimates of -$0.34 and low estimates of -$0.86.
Analysts are recommending an EPS of between -$1.57 and -$4.18 for the fiscal current year, implying an average EPS of -$2.67. EPS for the following year is -$2.59, with 8 analysts recommending between -$1.25 and -$4.44.
